ArticleAmerican health & drug benefits2019

Outcomes-Based Contracting for Disease-Modifying Therapies in Multiple Sclerosis: Necessary Conditions for Paradigm Adoption.

Cori Gray et al.PubMed ↗Full text ↗

No numbers read from the abstract.